Top news of the week: 09.06.2021.
Companies And Industries
Biogen shares rise as FDA nears ruling on controversial Alzheimer's drug
The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's (BIIB.O) aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment ...
Biogen’s big day is a Wall Street windfall for biotechs in Alzheimer’s
Investors see the FDA's decision on Aduhelm as evidence the agency has lowered the bar for approval of Alzheimer’s treatments.
Bayer picks up radiotherapeutics biotech to prop up dwindling sales in prostate cancer program
Amid sliding sales for prostate cancer drug Xofigo, Bayer will bolster its portfolio of targeted alpha therapies with the acquisition of radiotherapeutics biotech Noria Therapeutics and ...
Global Acceptance for Sinovac's COVID-19 Vaccine Grows Despite Disparate Data
While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine ...
COVID-19 News: Inovio's DNA Vaccine Candidate, Hearing Loss with Delta Variant and More
Please check out the biopharma industry's COVID-19 stories that are trending for June 8, 2021.
Good Day BIO: We need to act now on ag biotech | BIO
A new week—and BIO's new letter to the Biden administration on why and how we need to overcome trade barriers to agricultural biotechnology. We also look at why Black Americans are lagging ...
UK is talking to AstraZeneca about beta variant COVID jab
UK government says it is talking to AstraZeneca about a booster jab targeting the beta (B.1.351) COVID-19 variant, which may be able to evade current vaccines
Dr. Katalin Karikó receives 2022 Vilcek Prize for Excellence for pioneering vaccine research
The 2022 Vilcek Prize for Excellence in Biotechnology is awarded to Dr. Katalin Karikó for her research discoveries that rendered mRNA vaccines for COVID-19 possible.